← Back
$MPLT All transactions

MapLight Therapeutics, Inc.

▼ SELL

$ Value

$88K

Shares

3,316

Price

$27

Filed

Apr 17

Insider

Name

Kreitzer Anatol

Title

Chief Discovery Officer

CIK

0002021238

Roles

Officer

Transaction Details

Transaction Date

2026-04-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

256,612

Footnotes

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.6045 to $26.6093 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0002021238-26-000006

Form Type

4

Issuer CIK

0001770069

Kreitzer Anatol's History

Date Ticker Type Value
2026-04-15 MPLT $88K
2026-02-05 MPLT A $0
2026-02-05 MPLT A $0
2026-01-27 MPLT F $757K
2025-10-27 MPLT A $0
2025-10-27 MPLT A $0

Other Insiders at MPLT (90d)

Insider Bought Sold Last
Pavlov George $441K 2026-02-20
Garnett Timothy John $253K 2026-02-10
Kroeger Christopher A.
Chief Executive Officer
$521K 2026-04-16
GILLIS JONATHAN
CAAO and PAO
$96K 2026-04-15
Lillie James Woodruff
Chief Scientific Officer
$123K 2026-04-16
Hanson Kristopher
General Counsel
$49K 2026-04-16
Malenka Robert C. $1.6M 2026-04-15
Foff Erin Pennock
Chief Medical Officer
$87K 2026-04-16
Kreitzer Anatol
Chief Discovery Officer
2026-02-05
Setia Vishwas
Chief Financial Officer
$79K 2026-04-16